The PCOS women with low SHBG levels are more sensitive to MF therapy, while the effectiveness of MF in patients with normal or high SHBG levels and, as a consequence, without signs of HA is significantly less noticeable. This evidence concerns the gene SHBG and polycystic ovary syndrome.